US Stock MarketDetailed Quotes
NH NantHealth
- 1.3500
- 0.00000.00%
Close May 24 16:00 ET
37.09MMarket Cap-174P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open1.3500Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)27.47MShares2.630052wk High-0.15P/B2.71MFloat Cap1.350052wk Low--Dividend TTM2.01MShs Float315.0000Historical High--Div YieldTTM0.00%Amplitude1.2400Historical Low--Avg Price1Lot Size
NantHealth Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 40.52%-6.57M | -16.52%-32.26M | -32.84%-7.05M | 11.86%-5.02M | -30.77%-9.15M | -14.00%-11.05M | -64.29%-27.69M | -510.36%-5.3M | -8.55%-5.7M | 12.49%-6.99M |
| Net income from continuing operations | 23.25%-12.24M | -15.78%-67.78M | -53.61%-25.66M | -25.20%-13.66M | 18.92%-12.51M | -2.91%-15.95M | -3.72%-58.54M | 17.22%-16.71M | 1.21%-10.91M | 68.04%-15.43M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | 99.21%-4K | --0 | --0 | --0 |
| Depreciation and amortization | -26.53%2.95M | 1.71%15.99M | -0.99%4.08M | 3.05%4.02M | -0.44%3.89M | 5.47%4.01M | -6.24%15.72M | -1.10%4.12M | -9.33%3.9M | -3.27%3.9M |
| Deferred tax | 126.04%25K | -710.26%-632K | -443.14%-350K | -6,900.00%-68K | -47.50%-118K | 4.95%-96K | -239.13%-78K | -35.44%102K | -98.81%1K | -110.53%-80K |
| Other non cash items | -2,932.06%-3.71M | -17.68%3.04M | 630.06%9.08M | -0.22%-3.62M | -178.25%-2.56M | -95.30%131K | -79.10%3.69M | -87.30%1.24M | -465.86%-3.61M | -61.30%3.27M |
| Change In working capital | 1,084.67%5.52M | 62.02%12.18M | 1.76%4.63M | 82.42%7.41M | 46.20%693K | 64.38%-561K | 242.37%7.52M | 30.71%4.55M | 2,754.90%4.06M | 118.00%474K |
| -Change in receivables | -204.34%-793K | 95.74%-99K | 48.96%-684K | -139.75%-157K | -131.03%-18K | 152.89%760K | -147.79%-2.32M | -207.89%-1.34M | 182.12%395K | -98.17%58K |
| -Change in prepaid assets | 278.28%1.1M | -747.12%-881K | 34.06%1.11M | -54.13%-2.22M | 52.17%843K | -1,185.42%-617K | -100.69%-104K | 27.85%831K | -25.63%-1.44M | 182.65%554K |
| -Change in payables and accrued expense | 839.17%4.98M | 89.87%14.2M | 7.62%4.64M | 140.51%9.83M | 145.20%400K | -1,628.21%-674K | 170.46%7.48M | 22.38%4.32M | 17.49%4.09M | 79.81%-885K |
| -Change in other working capital | 883.33%235K | -142.12%-1.04M | -158.82%-440K | -103.62%-37K | -171.22%-532K | 41.18%-30K | 134.34%2.47M | 138.68%748K | 151.10%1.02M | 146.40%747K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 40.52%-6.57M | -16.52%-32.26M | -32.84%-7.05M | 11.86%-5.02M | -30.77%-9.15M | -14.00%-11.05M | -64.29%-27.69M | -510.36%-5.3M | -8.55%-5.7M | 12.49%-6.99M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.99%-1.26M | -14.80%-6.47M | -139.90%-2.32M | 42.72%-1.3M | -30.55%-1.66M | -5.43%-1.2M | -115.99%-5.64M | 30.63%-965K | 70.25%-2.26M | -3.93%-1.27M |
| Net PPE purchase and sale | -4.99%-1.26M | -27.36%-6.47M | -139.90%-2.32M | 24.05%-1.3M | -30.55%-1.66M | -5.43%-1.2M | 10.42%-5.08M | 30.63%-965K | 19.73%-1.71M | -3.93%-1.27M |
| Net business purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | -101.36%-556K | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.99%-1.26M | -14.80%-6.47M | -139.90%-2.32M | 42.72%-1.3M | -30.55%-1.66M | -5.43%-1.2M | -115.99%-5.64M | 30.63%-965K | 70.25%-2.26M | -3.93%-1.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,817.81%20.6M | -73.38%10.8M | 202.76%10.45M | -26.01%1.11M | 0 | -271.57%-758K | 7,411.17%40.58M | -1,175.53%-10.17M | 23.30%1.5M | 6,790.66%49.44M |
| Net issuance payments of debt | 2,905.63%21.94M | -73.72%10.78M | 201.67%10.45M | -26.65%1.11M | --0 | -191.79%-782K | 315,392.31%41.01M | -1,189.21%-10.28M | 44.66%1.52M | --50.04M |
| Proceeds from stock option exercised by employees | --0 | -91.75%24K | --0 | --0 | --0 | -62.50%24K | 70.18%291K | --109K | -66.67%57K | --61K |
| Net other financing activities | ---1.34M | ---- | ---- | ---- | ---- | ---- | 1.49%-728K | --0 | ---70K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,817.81%20.6M | -73.38%10.8M | 202.76%10.45M | -26.01%1.11M | --0 | -271.57%-758K | 7,411.17%40.58M | -1,175.53%-10.17M | 23.30%1.5M | 6,790.66%49.44M |
| Net cash flow | ||||||||||
| Beginning cash position | -88.67%3.56M | 29.96%31.4M | -94.91%2.44M | -86.17%7.51M | 39.75%18.35M | 29.96%31.4M | 278.77%24.16M | 75.31%47.83M | 39.61%54.31M | -73.13%13.13M |
| Current changes in cash | 198.12%12.77M | -485.24%-27.93M | 106.61%1.09M | 19.37%-5.21M | -126.23%-10.8M | -17.88%-13.01M | -59.37%7.25M | -437.62%-16.44M | 44.48%-6.46M | 513.80%41.18M |
| Effect of exchange rate changes | -717.39%-376K | 927.27%91K | 533.33%38K | 695.45%131K | -1,700.00%-32K | -1,633.33%-46K | 82.26%-11K | 109.38%6K | -269.23%-22K | --2K |
| End cash Position | -13.07%15.95M | -88.67%3.56M | -88.67%3.56M | -94.91%2.44M | -86.17%7.51M | 39.75%18.35M | 29.96%31.4M | 29.96%31.4M | 75.31%47.83M | 39.61%54.31M |
| Free cash flow | 36.05%-7.84M | -18.20%-38.74M | -49.32%-9.36M | 14.67%-6.32M | -30.74%-10.8M | -13.10%-12.25M | -45.48%-32.77M | -177.39%-6.27M | -0.41%-7.41M | 10.31%-8.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg